Dowling & Yahnke’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Dowling & Yahnke’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,409	Closed	-$1.82M	–	376
2021 Q1	$1.82M	Buy	8,409 +1,863	+28%	+$350K	0.12%	162
2020 Q4	$755K	Buy	6,546 +120	+2%	+$13.4K	0.05%	217
2020 Q3	$626K	Hold	6,426	–	–	0.05%	216
2020 Q2	$789K	Buy	6,426 +2,545	+66%	+$289K	0.07%	201
2020 Q1	$340K	Sell	3,881 -29	-0.7%	-$3.07K	0.03%	241
2019 Q4	$409K	Buy	3,910 +4	+0.1%	+$449	0.03%	247
2019 Q3	$449K	Hold	3,906	–	–	0.04%	235
2019 Q2	$673K	Buy	+3,906	New	+$676K	0.06%	216

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Dowling & Yahnke's GWPH Position: Q2 2021 in Review

Dowling & Yahnke sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 8,409 shares — an estimated $1.82M sold.

Dowling & Yahnke first reported a position in GWPH in Q2 2019 and held it in 8 quarters. The position peaked at $1.82M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Dowling & Yahnke reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Dowling & Yahnke sold 8,409 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.82M.
Dowling & Yahnke first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 8 quarters.
Dowling & Yahnke's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.82M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Dowling & Yahnke's 13F filing for Q2 2021, filed 21 Jul 2021.